Login / Signup

Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study.

Ahmad AminMitra ChitsazanSepideh TaghaviMaryam Ardeshiri
Published in: ESC heart failure (2015)
Triiodothyronine replacement by chronic liothyronine therapy seems to safely benefit stable HF patients with LT3S receiving optimal HF medications.
Keyphrases
  • replacement therapy
  • double blind
  • heart failure
  • acute heart failure
  • smoking cessation
  • placebo controlled
  • clinical trial
  • case report
  • study protocol
  • drug induced
  • phase ii
  • stem cells
  • cell therapy
  • open label